PolyNovo was established to continue the development and commercialisation of our medical polymer technology for bone and cartilage repair and replacement.
New Vision Biotechnology was granted a worldwide licence for CSIRO's patented process for refining the shark cartilage derived, chondroitin sulphate, a popular alternative arthritis medicine.
